Cargando…

Seroprevalence study of hepatitis A virus in Fars province, southern Iran

BACKGROUND: There are several studies on seroprevalence of hepatitis A virus (HAV) in adults in the Middle East. OBJECTIVES: To determine seroprevalence of HAV among adult population in Fars province, southern Iran. PATIENTS AND METHODS: In a cross-sectional study, we checked anti-HAV antibody (IgG)...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghavi, Seyed Alireza, Hosseini Asl, Mohammad Kazem, Talebzadeh, Mozaffar, Eshraghian, Ahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206696/
https://www.ncbi.nlm.nih.gov/pubmed/22706273
_version_ 1782215476207681536
author Taghavi, Seyed Alireza
Hosseini Asl, Mohammad Kazem
Talebzadeh, Mozaffar
Eshraghian, Ahad
author_facet Taghavi, Seyed Alireza
Hosseini Asl, Mohammad Kazem
Talebzadeh, Mozaffar
Eshraghian, Ahad
author_sort Taghavi, Seyed Alireza
collection PubMed
description BACKGROUND: There are several studies on seroprevalence of hepatitis A virus (HAV) in adults in the Middle East. OBJECTIVES: To determine seroprevalence of HAV among adult population in Fars province, southern Iran. PATIENTS AND METHODS: In a cross-sectional study, we checked anti-HAV antibody (IgG) in subjects refereed to our health care centers to perform laboratory tests before getting married between March 2008 and March 2009. Age-specific seroprevalence was also determined. Some risk factors like level of education, type of residence, job, numbers of family members, and access to treated water were also evaluated in these participants. RESULTS: From 1050 subjects studied, 927 (88.2%) had ant-HAV antibody; 123 (11.8%) were antibody negative. Among subjects aged < 20 years, the anti-HAV seroprevalence was the lowest (79.3%) followed by subjects aged 20-30 years (91.3%) and those > 30 years (99%) (p = 0.01). 85.1% of studied individuals in urban areas had anti-HAV IgG while 95.9% of subjects in rural regions were anti-HAV positive (p = 0.001). The seroprevalence of HAV antibody was significantly associated with number of family members (p = 0.001). CONCLUSION: HAV is highly prevalent in our region especially in rural areas. It is better to vaccinate the children for HAV by the time they receive HBV vaccine or when they are five years.
format Online
Article
Text
id pubmed-3206696
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-32066962011-11-15 Seroprevalence study of hepatitis A virus in Fars province, southern Iran Taghavi, Seyed Alireza Hosseini Asl, Mohammad Kazem Talebzadeh, Mozaffar Eshraghian, Ahad Hepat Mon Original Article BACKGROUND: There are several studies on seroprevalence of hepatitis A virus (HAV) in adults in the Middle East. OBJECTIVES: To determine seroprevalence of HAV among adult population in Fars province, southern Iran. PATIENTS AND METHODS: In a cross-sectional study, we checked anti-HAV antibody (IgG) in subjects refereed to our health care centers to perform laboratory tests before getting married between March 2008 and March 2009. Age-specific seroprevalence was also determined. Some risk factors like level of education, type of residence, job, numbers of family members, and access to treated water were also evaluated in these participants. RESULTS: From 1050 subjects studied, 927 (88.2%) had ant-HAV antibody; 123 (11.8%) were antibody negative. Among subjects aged < 20 years, the anti-HAV seroprevalence was the lowest (79.3%) followed by subjects aged 20-30 years (91.3%) and those > 30 years (99%) (p = 0.01). 85.1% of studied individuals in urban areas had anti-HAV IgG while 95.9% of subjects in rural regions were anti-HAV positive (p = 0.001). The seroprevalence of HAV antibody was significantly associated with number of family members (p = 0.001). CONCLUSION: HAV is highly prevalent in our region especially in rural areas. It is better to vaccinate the children for HAV by the time they receive HBV vaccine or when they are five years. Kowsar 2011-04-01 2011-04-01 /pmc/articles/PMC3206696/ /pubmed/22706273 Text en Copyright © 2011, Kowsar M.P. Co. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Taghavi, Seyed Alireza
Hosseini Asl, Mohammad Kazem
Talebzadeh, Mozaffar
Eshraghian, Ahad
Seroprevalence study of hepatitis A virus in Fars province, southern Iran
title Seroprevalence study of hepatitis A virus in Fars province, southern Iran
title_full Seroprevalence study of hepatitis A virus in Fars province, southern Iran
title_fullStr Seroprevalence study of hepatitis A virus in Fars province, southern Iran
title_full_unstemmed Seroprevalence study of hepatitis A virus in Fars province, southern Iran
title_short Seroprevalence study of hepatitis A virus in Fars province, southern Iran
title_sort seroprevalence study of hepatitis a virus in fars province, southern iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206696/
https://www.ncbi.nlm.nih.gov/pubmed/22706273
work_keys_str_mv AT taghaviseyedalireza seroprevalencestudyofhepatitisavirusinfarsprovincesoutherniran
AT hosseiniaslmohammadkazem seroprevalencestudyofhepatitisavirusinfarsprovincesoutherniran
AT talebzadehmozaffar seroprevalencestudyofhepatitisavirusinfarsprovincesoutherniran
AT eshraghianahad seroprevalencestudyofhepatitisavirusinfarsprovincesoutherniran